bioavailability of glp-1 treatments Oral Therapy: Pills vs Injections? Current Insights, Advantages and Challenges

This is particularly beneficial in places like Australia, where cost-efficiency is as much a priority as it is a necessity

Targeting dementia prevention with semaglutide: The case for APOE4 homozygotes [PMID: 40572012] Laboratory literature summary: Targeting dementia prevention with semaglutide: The case for APOE4 homozygotes

8 This means that GIP doesnt necessarily suppress glucagonit can also use glucagon to produce more glucose when blood sugar levels drop significantly

The risk of NAION may be as much as 7 times higher when GLP-1 medications are used

When a cell over-expresses NNMT, it does two costly things at once: it burns through methyl-donor capacity, and it diverts nicotinamide away from NAD+ regeneration into an inert metabolite (1-methylnicotinamide) that gets excreted

Second, prescribing does not necessarily equate to dispensing or treatment initiation